Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 9,102 shares at $5.95 ($55K) on 2024-10-29, disclosed to the SEC on 2024-10-30.
Scheduled sale ($55k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.06 | 1,697 | $10K | 18.7% |
| 2 | $6.06 | 5,105 | $31K | 56.3% |
| 3 | $5.95 | 2,300 | $14K | 24.9% |
| Total | $6.03 avg | 9,102 | $55K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $350K | — | Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |